{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:29:12Z","timestamp":1764001752682},"reference-count":24,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,24]],"date-time":"2006-01-24T00:00:00Z","timestamp":1138060800000},"content-version":"vor","delay-in-days":1394,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2002,4]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold> MMDM patients are typically young at onset with low body mass index, require insulin treatment for glycemic control, have insulin resistance, and do not develop ketosis on withdrawal of insulin. WHO's revised classification in 1999, based on the etiopathogenesis of the disease, identifies only two categories: type 1 diabetes and type 2 diabetes. MMDM could be considered as type 1b diabetes. Genetic and immunological studies were done on MDDM patients (<jats:styled-content><jats:italic>n<\/jats:italic>= 72<\/jats:styled-content>) from Cuttack and healthy controls to understand and to justify its inclusion in the category of type 1b diabetes. Antibodies (Abs) to tyrosine pyrophosphatase (IA2\u2010Abs), glutamate decarboxylase 65 (GAD65\u2010Abs), and other minor markers like ICA12 Abs and tissue transglutaminase Abs (TTG\u2010Abs) were studied. HLA\u2010DR and DQ were studied for the genetic markers. Of the MMDM patients 30% were positive for either GAD65 or IA\u20102 antibodies, and 14% were positive for ICA12 antibodies. All three antibody markers together accounted for 39% of PDDM patients, as some patients were positive for more than one autoantibody. TTG antibodies (specific for Celiac disease) were present in 14\/71 (20%) of MMDM patients compared to 3\/122 (2%) controls. All four autoantibodies accounted for 53% of PDDM patients, leaving 47% of patients free of known autoantibodies. The autoantibody\u2010negative PDDM patients were analyzed for HLA and MICA markers, showing that DR7\u2010DQ9 and MICA allele 9 are increased in this group compared to healthy controls, which suggests an autoimmune response to an unknown dietary autoantigen. We conclude from our data that an autoimmune mechanism is involved in the etiology of MMDM. In addition, the presence of silent celiac disease seen with MMDM patients, which has not yet been reported, is significant. It is important to note that subclinical celiac disease exists with diabetes mellitus and must be considered in the diagnosis of MMDM.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2002.tb02956.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T22:58:05Z","timestamp":1279666685000},"page":"138-143","source":"Crossref","is-referenced-by-count":18,"title":["Molecular Mechanisms Involved in the Etiopathogenesis of Malnutrition\u2010Modulated Diabetes Mellitus"],"prefix":"10.1111","volume":"958","author":[{"given":"A.","family":"KANUNGO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. C.","family":"SAMAL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. B.","family":"SANJEEVI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,1,24]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"World Health Organization. 1985. Diabetes Mellitus: Report of a WHO Study Group. Technical Report Series No. 727. WHO. Geneva."},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"20","author":"World Health Organization","year":"1997","journal-title":"Diabetes Care"},{"key":"e_1_2_6_4_2","unstructured":"World Health Organization. 1999. Definition Diagnosis and Classification of Diabetes Mellitus and Its Complications. Report of a WHO Consultation Part 1: Diagnosis and Classification of Diabetes Mellitus. WHO. Geneva."},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112903"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91241-2"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.3109\/08916939409009539"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(95)00139-2"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00408469"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116195"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117822"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116431"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116714"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2337\/diab.43.3.459","article-title":"Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand binding assay","volume":"43","author":"Petersen J.","year":"1994","journal-title":"Diabetes"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.3.846"},{"key":"e_1_2_6_16_2","first-page":"167","article-title":"Glutamic acid decaeboxylase in IDDM","volume":"9","author":"Sanjeevi C.B.","year":"1996","journal-title":"Diabetes Nutr. Metab."},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199707)14:7<532::AID-DIA403>3.0.CO;2-6"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.43.10.1254"},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2337\/diab.43.11.1304","article-title":"Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibodies positive relatives","volume":"43","author":"Bingley P.","year":"1994","journal-title":"Diabetes"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.172.3.789"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116556"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1089\/dna.1994.13.505"},{"key":"e_1_2_6_23_2","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.4049\/jimmunol.155.11.5419","article-title":"Identification of protein tyrosine phosphatase\u2010like IA\u20102 as the insulin\u2010dependent diabetes related 37\/40K autoantigen and a target of islet\u2010cell antibodies","volume":"155","author":"Bonifacio E.","year":"1995","journal-title":"J. Immunol."},{"key":"e_1_2_6_24_2","first-page":"60","article-title":"Prevalence of GAD65 autoantibodies in South Indian patients with IDDM and their parents","volume":"10","author":"Sanjeevi C.B.","year":"1997","journal-title":"Diabetes Nutr. Metab."},{"issue":"1","key":"e_1_2_6_25_2","first-page":"A72","article-title":"Antibodies to ICA512 and GAD65 in IDDM patients from Eastern India [abstr.]","volume":"40","author":"Sanjeevi C.B.","year":"1997","journal-title":"Diabetologia"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2002.tb02956.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2002.tb02956.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T22:56:57Z","timestamp":1695682617000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2002.tb02956.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["10.1111\/j.1749-6632.2002.tb02956.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2002.tb02956.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}